BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11242597)

  • 1. Pathogenetic mechanisms of polycythemia vera and congenital polycythemic disorders.
    Prchal JT
    Semin Hematol; 2001 Jan; 38(1 Suppl 2):10-20. PubMed ID: 11242597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular basis for polycythemia.
    Prchal JF; Prchal JT
    Curr Opin Hematol; 1999 Mar; 6(2):100-9. PubMed ID: 10088640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycythemia vera and other primary polycythemias.
    Prchal JT
    Curr Opin Hematol; 2005 Mar; 12(2):112-6. PubMed ID: 15725900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in the molecular biology of congenital polycythemias and polycythemia vera.
    Gregg XT; Prchal JT
    Curr Hematol Rep; 2005 May; 4(3):238-42. PubMed ID: 15865879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Benign erythrocytosis" and other familial and congenital polycythemias.
    Prchal JT; Sokol L
    Eur J Haematol; 1996 Oct; 57(4):263-8. PubMed ID: 8982288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital and inherited polycythemia.
    Kralovics R; Prchal JT
    Curr Opin Pediatr; 2000 Feb; 12(1):29-34. PubMed ID: 10676771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary polycythemias.
    Prchal JT
    Curr Opin Hematol; 1995 Mar; 2(2):146-52. PubMed ID: 9371985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal hematopoiesis in familial polycythemia vera suggests the involvement of multiple mutational events in the early pathogenesis of the disease.
    Kralovics R; Stockton DW; Prchal JT
    Blood; 2003 Nov; 102(10):3793-6. PubMed ID: 12829587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lessons from familial myeloproliferative disorders.
    Skoda R; Prchal JT
    Semin Hematol; 2005 Oct; 42(4):266-73. PubMed ID: 16210040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycythemia and oxygen sensing.
    Maran J; Prchal J
    Pathol Biol (Paris); 2004 Jun; 52(5):280-4. PubMed ID: 15217714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of "increased" hemoglobin in the JAK2 mutations era: a diagnostic algorithm based on genetic tests.
    Tefferi A; Pardanani A
    Mayo Clin Proc; 2007 May; 82(5):599-604. PubMed ID: 17493421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular biology of polycythemias.
    Prchal JT
    Intern Med; 2001 Aug; 40(8):681-7. PubMed ID: 11518102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two new EPO receptor mutations: truncated EPO receptors are most frequently associated with primary familial and congenital polycythemias.
    Kralovics R; Indrak K; Stopka T; Berman BW; Prchal JF; Prchal JT
    Blood; 1997 Sep; 90(5):2057-61. PubMed ID: 9292543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of JAK2 V617F mutation, spontaneous erythropoiesis and megakaryocytopoiesis, hypersensitive platelets, activated leukocytes, and endothelial cells in the etiology of thrombotic manifestations in polycythemia vera and essential thrombocythemia.
    Bellucci S; Michiels JJ
    Semin Thromb Hemost; 2006 Jun; 32(4 Pt 2):381-98. PubMed ID: 16810614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The gene encoding hematopoietic cell phosphatase (SHP-1) is structurally and transcriptionally intact in polycythemia vera.
    Asimakopoulos FA; Hinshelwood S; Gilbert JG; Delibrias CC; Göttgens B; Fearon DT; Green AR
    Oncogene; 1997 Mar; 14(10):1215-22. PubMed ID: 9121771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycythemia vera: scientific advances and current practice.
    Tefferi A; Spivak JL
    Semin Hematol; 2005 Oct; 42(4):206-20. PubMed ID: 16210034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia.
    Teofili L; Giona F; Martini M; Cenci T; Guidi F; Torti L; Palumbo G; Amendola A; Foà R; Larocca LM
    J Clin Oncol; 2007 Mar; 25(9):1048-53. PubMed ID: 17369568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin and erythropoiesis: polycythemias due to disruption of oxygen homeostasis.
    Prchal JT; Pastore YD
    Hematol J; 2004; 5 Suppl 3():S110-3. PubMed ID: 15190290
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased erythropoiesis in polycythemia vera is associated with increased erythroid progenitor proliferation and increased phosphorylation of Akt/PKB.
    Dai C; Chung IJ; Krantz SB
    Exp Hematol; 2005 Feb; 33(2):152-8. PubMed ID: 15676208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoiesis in polycythemia vera is hyper-proliferative and has accelerated maturation.
    Bruchova H; Yoon D; Agarwal AM; Swierczek S; Prchal JT
    Blood Cells Mol Dis; 2009; 43(1):81-7. PubMed ID: 19264517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.